| Intrinsic Valuation of: ZYDUSLIFE | |||||||||||
| Free Cash Flow Average and Growth over past 5Y | Key Statistics | ||||||||||
| Year | FCF | FCF (FCF/Revenue) | |||||||||
| 2020 | - | - | EPS (FY) | 49 | Market Cap | ₹1,018B | |||||
| 2021 | - | - (-) | P/E Ratio | 21 | Total Asset | ₹372B | |||||
| 2022 | ₹9B | - (-) | Net Income | ₹45B | Total Debt | ₹0 | |||||
| 2023 | ₹17B | 83.8% (61.5%) | EBITDA | ₹70B | Total Liab | ₹108B | |||||
| 2024 | ₹23B | 38.1% (22.5%) | Opr Margin | 26.49 | Debt/Equity | - | |||||
| 2025 | ₹51B | 121.2% (86.4%) | PreTax Margin | 26.07 | BV/Share | 154 | |||||
| 5Y Average FCF | ₹25B | 15.0% (56.8%) | |||||||||
| Overall Market Assumptions: | |||||||||||
| Assumptions: | P/E for No-Growth Company: | 7.0 | |||||||||
| Perpetual Growth Rate (g): | 2.48% | Historical US Bond Yield: | 4.40% | ||||||||
| Discount Rate (WACC): | 7.00% | Current US Bond Yield: | 3.48% | ||||||||
| Forcasting Future Free Cash Flow for next 6Y | Modified Benjamin Graham's Intrinsic Value | ||||||||||
| Year | FCF Projection (15.0%) | ||||||||||
| 2026 | ₹49B | MBG Intrinsic Value | ₹439 | ||||||||
| 2027 | ₹55B | ||||||||||
| 2028 | ₹61B | ||||||||||
| 2029 | ₹66B | ||||||||||
| 2030 | ₹69B | ||||||||||
| 2031 | ₹71B | ||||||||||
| Terminal Value | ₹1,600B | Net Worth/Share | ₹262 | ||||||||
| DCF Valuation | DCF Valuation "What If" Scenario Table | ||||||||||
| Enterprise Value | ₹1,357B | Growth Rate | |||||||||
| (+) Cash & Cash Equivalents | ₹8B | ₹1,356 | 1.5% | 2.0% | 2.5% | 3.0% | 3.5% | ||||
| (-) Total Debt | ₹0 | WACC | 6.5% | 1,273 | 1,386 | 1,527 | 1,708 | 1,949 | |||
| Equity Value | ₹1,365B | 7.1% | 1,131 | 1,217 | 1,321 | 1,450 | 1,615 | ||||
| Shares Outstanding | 1,006,233,990 | 7.8% | 1,015 | 1,082 | 1,161 | 1,257 | 1,376 | ||||
| 8.4% | 921 | 974 | 1,036 | 1,110 | 1,198 | ||||||
| DCF Intrinsic Value | ₹1,356 | 9.0% | 843 | 886 | 936 | 994 | 1,063 | ||||
| Analyzed by QuantJuice (2025) | |||||||||||